Summary Rat mamary tumour cells were grafted to parietal bones as an experimental model to study the nature of bone resorption around metastatic carcinomas in the skeleton. After periods of growth of from 6 to 56 days bones and tumours were removed and embedded in epoxy resin. The appearances were compared with those found when whole parathyroid glands were grafted in similar positions. Tumours were evident in all animals at the time of death and some were palpable five days after grafting. In 15 of the 21 animals with tumour, osteoclasts and resorption were found, and in only two of these were the tumour cells not separated from the bone surfaces. In 6 animals killed between 6 and 12 days after grafting there was new bone formation without resorption. There were osteoclasts and resorption under the grafted parathyroid glands which were always separated from the resorbing cells by fibrous tissue. The appearances of the bone surfaces under the tumours and the parathyroid glands suggested that the resorption in both situations was similar, was brought about by the secretion of a locally active agent and mediated by osteoclasts. This is further support for the role of osteoclasts in bone resorption around metastatic carcinomas.
The skeleton is a common site for metastases of carcinomas of the mammary, prostate and thyroid glands. It has been claimed that over 80% of women with mammary carcinoma have bone metastases (Jaffe, 1958) and these are often associated with resorption. There are conflicting ideas about the way this resorption is brought about. Older reports (Milch & Changus, 1956 ) considered resorption to be largely independent of osteoclasts. There is a greater tendency now to accept the role of osteoclasts as being important (Teitelbaum, 1978 unpublished; Carter & Pittam, 1980; Sissons, 1980; Tsao et al., 1981) but the view is still held that the malignant cells themselves can resorb bone (Eilon & Mundy, 1978; Galasko et al., 1979; Carter et al., 1983) .
As part of a broader study of the breakdown of both mineralized and unmineralized connective tissue matrices (O'Grady et al., 1981 (O'Grady et al., , 1982 , we have used an experimental model to examine the bone resorption associated with the growth of transplanted malignant tumours on the parietal bones of rats and compared it with that caused by autografts of parathyroid glands in similar positions (Barnicot, 1948; Chang, t951) . The tumours were produced by injecting into the parietal periosteum cultured neoplastic cells, derived from rat mammary carcinomas.
Materials and methods

Grafting
Tumours The primary tumours used in these experiments arose spontaneously in the mammary glands of three DA rats of an inbred strain (Festing, 1980) maintained in the Department of Pathology, University of Sydney. After a number of transplantations, neoplastic cell lines were established and maintained as described previously (O'Grady et al., 1981 (O'Grady et al., , 1982 . Both cultured cells and fragments of the original tumours were stored in liquid nitrogen. After the percutaneous injection into the parietal periosteum of 106 cultured neoplastic cells, suspended in PBS tumours grew on the surfaces of the parietal bones of syngeneic rats weighing 100-150g. The rats were killed at intervals of from 6 to 56 days after these injections.
Parathyroid glands Parathyroid glands were dissected free of thyroid tissue with the aid of a binocular microscope and were autografted whole through a skin incision under the periosteum of the parietal bones of 12 rats weighing 80-150g Histological examination showed osteoclasts and bone resorption (Figure 1 ) under the tumours in 15 rats, the earliest 11 days after grafting. In 11, the osteoclasts and the area of resorption were separated from the tumour cells by a considerable band of fibrous tissue ( Figure 2 ). In two rats the osteoclasts and bone had only a thin layer of nontumour cells between them and the tumour cells ( Figure 3 ) and in two others both osteoclasts and tumour cells were in contact with the bone surface ( Figure 4) .
In 6 rats with tumour transplants of up to 12 days duration there was new bone formation without any resorption of the original bone. In three, after longer periods of growth, newly formed bone was present in association with resorption.
Parathyroid grafts Most of the grafts survived well and in one only was there considerable lipid in the parenchymal cells. These grafts were of whole organs and not suspensions of cells as was the case with the tumours.
Bone resorption was evident under the glands after 5 days, with deep penetration after eight days. Complete perforation was seen in seven rats between nine and twelve days. The bone surface in the crater under the gland was usually covered with osteoclasts ( Figure 5 ), although there were also some osteoblasts present in three rats. The parathyroid tissue was not in contact with the bone surface of the osteoclasts but separated from them by a layer of fibrous tissue.
Discussion
Various mechanisms have been proposed to explain bone resorption associated with tumours.
Some observers have noted osteolysis by tumours ostensibly in the presence of very few osteoclasts or in their complete absence (Jaffe, 1958; Milch & Changus, 1958; Shivas et al., 1963) (Neuman et al., 1960) . The cell lines we have used, synthesize and secrete collagenase and plasminogen activator (O'Grady et al., 1981 (O'Grady et al., , 1982 and it is likely that they can produce other hydrolytic enzymes that are capable of breaking down other matrix components after demineralization. Some in vitro studies (Eilon & Mundy, 1978) present in considerable numbers adjacent to well established tumour transplants, congregated in areas of resorption. Osteoclastic action has become much more complicated than appeared 15 years or so ago. Not only are the cells thought to be part of the macrophage family (Gothlin & Ericsson, 1973) but they respond to an increasing number of chemical agents in addition to the archetypal parathyroid hormone (PTH). Some of these, including PTH, have been shown to be produced by tumours e.g. Vitamin D-related substances, osteoclast activating factor (OAF) Mundy et al., 1974) , prostaglandins (PGs) and growth factors (Tashjian, 1981) . Like PTH, they possibly all affect osteoclasts indirectly through osteoblasts (O'Grady & Cameron, 1972; Rodan & Martin, 1981; Silve et al., 1982) (or perhaps other cells) and of them all, PGs and growth factors are likely candidates in mammary tumour bone metastases. Various metabolites of arachidonic acid are potent stimulators of bone resorption and these are produced by tumour, bone and other cells. Seyberth, 1978; Dominguez & Mundy, 1980) . Bone remodelling responds readily to stress, and pressure causes resorption (Storey & Feik, 1982; Pollard et al., 1984) . It has been proposed that "pressure atrophy" (Shivas et al., 1963) leading to necrosis, or "growth pressure" cause resorption (Jaffe, 1958) but no explanation has been offered as to just how the mineralized tissue was removed, although osteoclasts were said not to be involved. In our experiments resorption took a few days to become apparent during which time any pressure differences resulting from the injection of the cells should have been dissipated quickly. Any pressure as the tumour mass increased in size would have been equalized by changes in the very loose areolar tissue below the freely movable skin. Newly formed bone was conspicuous under the short term grafts and the trau;na of injection may have contributed to its formation. New bone formation is often found with secondary carcinomas (Willis, 1952; Jaffe, 1958) and can be easily recognised histologically even when covered by tumour cells. It is interesting that the tumour cells themselves have never been accused of laying down this new bone.
While conceding that resorption in the parietal bones could have been the result of pressure, the results reported here show that their morphological appearances closely resemble those found when a parathyroid gland is transplanted to periosteum. This technique was first used over 30 years ago as part of the experimental demonstration of the effect of PTH, when Barnicot (1948) and Chang (1951) found that parathyroid grafts produced rapid osteoclastic resorption, whereas grafts of a variety of other tissues had insignificant effects. It prompted us to use the same approach with tumours. Like most of the tumour transplants, the parathyroid glands were separated from the localised resorption areas by mesenchymal tissue and the resorption cavities had many more osteoclasts than were found on undisturbed bone surfaces. Given the known role of osteoclasts in resorption and the relationship of PTH from the gland transplant to Qesteoclast activity, it seems logical to presume that the resorption under the tumour transplants was mediated by osteoclastactivating chemical agents from the tumour. These could have been, for example, prostaglandins produced by the malignant cells, growth factors specified by their oncogenes or a combination of both.
We conclude that, in our in vivo experimental model, the bone resorption under these mammary tumours was brought about by osteoclasts. It still remains to be demonstrated if resorption continues in the absence of osteoclasts and if neoplastic or other cells in metastatic tumours have the capacity to break down bone matrix.
